LineaRx, a subsidiary of molecular technology company Applied DNA Sciences, has entered into a joint development agreement with Italian biotech Takis over developing DNA-based anti-cancer vaccines for humans.

The agreement also includes an alliance with Evvivax, a Takis company, related to the discovery and development of similar vaccines for the veterinary market.